HEADER TRANSCRIPTION 18-NOV-10 2XYJ TITLE NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL TITLE 2 DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA TITLE 3 AGONISTS WITH HIGH POTENCY AND IN-VIVO EFFICACY COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 165-441; COMPND 5 SYNONYM: PPAR-DELTA, NUCI, NUCLEAR HORMONE RECEPTOR 1, NUC1, NUCLEAR COMPND 6 RECEPTOR SUBFAMILY 1 GROUP C MEMBER 2, PEROXISOME PROLIFERATOR- COMPND 7 ACTIVATED RECEPTOR BETA, PPAR-BETA, PEROXISOME PROLIFERATOR-ACTIVATED COMPND 8 RECEPTOR; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR J.-P.MARQUETTE,M.MATHIEU REVDAT 4 01-MAY-24 2XYJ 1 REMARK REVDAT 3 16-OCT-19 2XYJ 1 REMARK REVDAT 2 25-MAY-11 2XYJ 1 JRNL REVDAT 1 23-FEB-11 2XYJ 0 JRNL AUTH S.KEIL,H.MATTER,K.SCHONAFINGER,M.GLIEN,M.MATHIEU, JRNL AUTH 2 J.-P.MARQUETTE,N.MICHOT,S.HAAG-DIERGARTEN,M.URMANN,W.WENDLER JRNL TITL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL JRNL TITL 2 DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA JRNL TITL 3 / DELTA AGONISTS WITH HIGH POTENCY AND IN-VIVO EFFICACY JRNL REF CHEMMEDCHEM V. 6 633 2011 JRNL REFN ISSN 1860-7179 JRNL PMID 21400663 JRNL DOI 10.1002/CMDC.201100047 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 28022 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2321 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4202 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 144 REMARK 3 SOLVENT ATOMS : 104 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 204-207 AND 229-233 ARE NOT REMARK 3 VISIBLE. LIGAND MOLECULES 3 AND 4 ARE AT THE INTERFACE BETWEEN REMARK 3 PROTEINS A AND B. REMARK 4 REMARK 4 2XYJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-NOV-10. REMARK 100 THE DEPOSITION ID IS D_1290046243. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-NOV-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28063 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 37.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.26300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: IN-HOUSE STRUCTURE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350 11%, TRIS 100MM PH 8, CACL2 REMARK 280 300MM, PH 8.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 18.87450 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 56.00450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 18.87450 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 56.00450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 154 REMARK 465 LYS A 155 REMARK 465 LYS A 156 REMARK 465 GLY A 157 REMARK 465 HIS A 158 REMARK 465 HIS A 159 REMARK 465 HIS A 160 REMARK 465 HIS A 161 REMARK 465 HIS A 162 REMARK 465 HIS A 163 REMARK 465 GLY A 164 REMARK 465 GLY A 165 REMARK 465 SER A 166 REMARK 465 GLN A 167 REMARK 465 TYR A 168 REMARK 465 ASN A 169 REMARK 465 PRO A 170 REMARK 465 GLN A 171 REMARK 465 VAL A 172 REMARK 465 LYS A 204 REMARK 465 ALA A 205 REMARK 465 LEU A 231 REMARK 465 VAL A 232 REMARK 465 ASN A 233 REMARK 465 TYR A 441 REMARK 465 MET B 154 REMARK 465 LYS B 155 REMARK 465 LYS B 156 REMARK 465 GLY B 157 REMARK 465 HIS B 158 REMARK 465 HIS B 159 REMARK 465 HIS B 160 REMARK 465 HIS B 161 REMARK 465 HIS B 162 REMARK 465 HIS B 163 REMARK 465 GLY B 164 REMARK 465 GLY B 165 REMARK 465 SER B 166 REMARK 465 GLN B 167 REMARK 465 TYR B 168 REMARK 465 ASN B 169 REMARK 465 PRO B 170 REMARK 465 GLN B 171 REMARK 465 VAL B 172 REMARK 465 LYS B 204 REMARK 465 ALA B 205 REMARK 465 SER B 206 REMARK 465 HIS B 207 REMARK 465 LYS B 229 REMARK 465 GLN B 230 REMARK 465 LEU B 231 REMARK 465 VAL B 232 REMARK 465 ASN B 233 REMARK 465 TYR B 441 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2040 O HOH A 2041 2.15 REMARK 500 OG SER A 319 O HOH A 2039 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 362 C - N - CD ANGL. DEV. = -12.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 229 2.60 -64.99 REMARK 500 SER A 269 -22.77 92.00 REMARK 500 LEU A 357 44.51 -94.71 REMARK 500 VAL B 227 -10.37 -150.71 REMARK 500 SER B 269 -7.54 83.00 REMARK 500 LEU B 357 47.50 -87.34 REMARK 500 GLU B 424 70.33 -100.37 REMARK 500 THR B 425 3.60 -65.79 REMARK 500 LYS B 438 -43.41 -22.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WLM A 1441 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WLM B 1441 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WLM A 1442 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WLM B 1442 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1PE A 1443 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Y0S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PPAR DELTA COMPLEXED WITH GW2331 REMARK 900 RELATED ID: 2AWH RELATED DB: PDB REMARK 900 HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1 REMARK 900 RELATED ID: 2XYX RELATED DB: PDB REMARK 900 NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL REMARK 900 DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA REMARK 900 AGONISTS WITH HIGH POTENCY AND IN -VIVO EFFICACY REMARK 900 RELATED ID: 2B50 RELATED DB: PDB REMARK 900 HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 2 REMARK 900 RELATED ID: 2BAW RELATED DB: PDB REMARK 900 HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1 REMARK 900 RELATED ID: 2GWX RELATED DB: PDB REMARK 900 MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR- REMARK 900 ACTIVATED RECEPTORS REMARK 900 RELATED ID: 2XYW RELATED DB: PDB REMARK 900 NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL REMARK 900 DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA REMARK 900 AGONISTS WITH HIGH POTENCY AND IN -VIVO EFFICACY REMARK 900 RELATED ID: 1GWX RELATED DB: PDB REMARK 900 MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR- REMARK 900 ACTIVATED RECEPTORS REMARK 900 RELATED ID: 2J14 RELATED DB: PDB REMARK 900 3,4,5-TRISUBSTITUTED ISOXAZOLES AS NOVEL PPARDELTA AGONISTS: PART2 REMARK 900 RELATED ID: 3GWX RELATED DB: PDB REMARK 900 MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR- REMARK 900 ACTIVATED RECEPTORS DBREF 2XYJ A 165 441 UNP Q03181 PPARD_HUMAN 165 441 DBREF 2XYJ B 165 441 UNP Q03181 PPARD_HUMAN 165 441 SEQADV 2XYJ MET A 154 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ LYS A 155 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ LYS A 156 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ GLY A 157 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ HIS A 158 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ HIS A 159 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ HIS A 160 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ HIS A 161 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ HIS A 162 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ HIS A 163 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ GLY A 164 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ MET B 154 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ LYS B 155 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ LYS B 156 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ GLY B 157 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ HIS B 158 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ HIS B 159 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ HIS B 160 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ HIS B 161 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ HIS B 162 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ HIS B 163 UNP Q03181 EXPRESSION TAG SEQADV 2XYJ GLY B 164 UNP Q03181 EXPRESSION TAG SEQRES 1 A 288 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY GLY SER SEQRES 2 A 288 GLN TYR ASN PRO GLN VAL ALA ASP LEU LYS ALA PHE SER SEQRES 3 A 288 LYS HIS ILE TYR ASN ALA TYR LEU LYS ASN PHE ASN MET SEQRES 4 A 288 THR LYS LYS LYS ALA ARG SER ILE LEU THR GLY LYS ALA SEQRES 5 A 288 SER HIS THR ALA PRO PHE VAL ILE HIS ASP ILE GLU THR SEQRES 6 A 288 LEU TRP GLN ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU SEQRES 7 A 288 VAL ASN GLY LEU PRO PRO TYR LYS GLU ILE SER VAL HIS SEQRES 8 A 288 VAL PHE TYR ARG CYS GLN CYS THR THR VAL GLU THR VAL SEQRES 9 A 288 ARG GLU LEU THR GLU PHE ALA LYS SER ILE PRO SER PHE SEQRES 10 A 288 SER SER LEU PHE LEU ASN ASP GLN VAL THR LEU LEU LYS SEQRES 11 A 288 TYR GLY VAL HIS GLU ALA ILE PHE ALA MET LEU ALA SER SEQRES 12 A 288 ILE VAL ASN LYS ASP GLY LEU LEU VAL ALA ASN GLY SER SEQRES 13 A 288 GLY PHE VAL THR ARG GLU PHE LEU ARG SER LEU ARG LYS SEQRES 14 A 288 PRO PHE SER ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA SEQRES 15 A 288 VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU SEQRES 16 A 288 ALA LEU PHE ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG SEQRES 17 A 288 PRO GLY LEU MET ASN VAL PRO ARG VAL GLU ALA ILE GLN SEQRES 18 A 288 ASP THR ILE LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA SEQRES 19 A 288 ASN HIS PRO ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU SEQRES 20 A 288 GLN LYS MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS SEQRES 21 A 288 ALA GLN MET MET GLN ARG ILE LYS LYS THR GLU THR GLU SEQRES 22 A 288 THR SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP SEQRES 23 A 288 MET TYR SEQRES 1 B 288 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY GLY SER SEQRES 2 B 288 GLN TYR ASN PRO GLN VAL ALA ASP LEU LYS ALA PHE SER SEQRES 3 B 288 LYS HIS ILE TYR ASN ALA TYR LEU LYS ASN PHE ASN MET SEQRES 4 B 288 THR LYS LYS LYS ALA ARG SER ILE LEU THR GLY LYS ALA SEQRES 5 B 288 SER HIS THR ALA PRO PHE VAL ILE HIS ASP ILE GLU THR SEQRES 6 B 288 LEU TRP GLN ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU SEQRES 7 B 288 VAL ASN GLY LEU PRO PRO TYR LYS GLU ILE SER VAL HIS SEQRES 8 B 288 VAL PHE TYR ARG CYS GLN CYS THR THR VAL GLU THR VAL SEQRES 9 B 288 ARG GLU LEU THR GLU PHE ALA LYS SER ILE PRO SER PHE SEQRES 10 B 288 SER SER LEU PHE LEU ASN ASP GLN VAL THR LEU LEU LYS SEQRES 11 B 288 TYR GLY VAL HIS GLU ALA ILE PHE ALA MET LEU ALA SER SEQRES 12 B 288 ILE VAL ASN LYS ASP GLY LEU LEU VAL ALA ASN GLY SER SEQRES 13 B 288 GLY PHE VAL THR ARG GLU PHE LEU ARG SER LEU ARG LYS SEQRES 14 B 288 PRO PHE SER ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA SEQRES 15 B 288 VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU SEQRES 16 B 288 ALA LEU PHE ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG SEQRES 17 B 288 PRO GLY LEU MET ASN VAL PRO ARG VAL GLU ALA ILE GLN SEQRES 18 B 288 ASP THR ILE LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA SEQRES 19 B 288 ASN HIS PRO ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU SEQRES 20 B 288 GLN LYS MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS SEQRES 21 B 288 ALA GLN MET MET GLN ARG ILE LYS LYS THR GLU THR GLU SEQRES 22 B 288 THR SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP SEQRES 23 B 288 MET TYR HET WLM A1441 32 HET WLM A1442 32 HET 1PE A1443 16 HET WLM B1441 32 HET WLM B1442 32 HETNAM WLM 5-CHLORO-2-METHOXY-N-[2-[4-[(5-PROPAN-2-YL-1,3,4- HETNAM 2 WLM THIADIAZOL-2-YL)SULFAMOYL]PHENYL]ETHYL]BENZAMIDE HETNAM 1PE PENTAETHYLENE GLYCOL HETSYN 1PE PEG400 FORMUL 3 WLM 4(C21 H23 CL N4 O4 S2) FORMUL 5 1PE C10 H22 O6 FORMUL 8 HOH *104(H2 O) HELIX 1 1 ALA A 173 PHE A 190 1 18 HELIX 2 2 THR A 193 GLY A 203 1 11 HELIX 3 3 ASP A 215 LEU A 226 1 12 HELIX 4 4 GLU A 240 SER A 266 1 27 HELIX 5 5 SER A 269 LEU A 273 5 5 HELIX 6 6 PHE A 274 ALA A 295 1 22 HELIX 7 7 ARG A 314 SER A 319 1 6 HELIX 8 8 ILE A 328 ALA A 340 1 13 HELIX 9 9 ASP A 344 LEU A 357 1 14 HELIX 10 10 ASN A 366 HIS A 389 1 24 HELIX 11 11 TYR A 394 GLU A 424 1 31 HELIX 12 12 HIS A 430 LYS A 438 1 9 HELIX 13 13 ALA B 173 PHE B 190 1 18 HELIX 14 14 THR B 193 GLY B 203 1 11 HELIX 15 15 ASP B 215 LYS B 224 1 10 HELIX 16 16 GLU B 240 SER B 266 1 27 HELIX 17 17 PHE B 274 ALA B 295 1 22 HELIX 18 18 ALA B 306 GLY B 308 5 3 HELIX 19 19 ARG B 314 SER B 319 1 6 HELIX 20 20 ARG B 321 ALA B 340 1 20 HELIX 21 21 ASP B 344 LEU B 357 1 14 HELIX 22 22 ASN B 366 HIS B 389 1 24 HELIX 23 23 TYR B 394 GLU B 424 1 31 HELIX 24 24 HIS B 430 ASP B 439 1 10 SHEET 1 AA 4 PHE A 211 ILE A 213 0 SHEET 2 AA 4 GLY A 310 THR A 313 1 O PHE A 311 N ILE A 213 SHEET 3 AA 4 GLY A 302 VAL A 305 -1 O LEU A 303 N VAL A 312 SHEET 4 AA 4 VAL A 298 ASN A 299 -1 O ASN A 299 N GLY A 302 SHEET 1 BA 4 PHE B 211 ILE B 213 0 SHEET 2 BA 4 GLY B 310 THR B 313 1 O PHE B 311 N ILE B 213 SHEET 3 BA 4 GLY B 302 VAL B 305 -1 O LEU B 303 N VAL B 312 SHEET 4 BA 4 VAL B 298 ASN B 299 -1 O ASN B 299 N GLY B 302 CISPEP 1 LYS A 322 PRO A 323 0 8.77 SITE 1 AC1 16 LEU A 219 TRP A 228 PHE A 246 CYS A 249 SITE 2 AC1 16 THR A 252 THR A 253 PHE A 291 VAL A 312 SITE 3 AC1 16 PHE A 324 ILE A 327 ILE A 328 HIS A 413 SITE 4 AC1 16 HOH A2062 HOH A2063 HOH A2064 HOH A2065 SITE 1 AC2 17 LEU B 219 VAL B 245 PHE B 246 ARG B 248 SITE 2 AC2 17 CYS B 249 THR B 252 THR B 253 PHE B 291 SITE 3 AC2 17 LEU B 294 VAL B 305 LEU B 317 PHE B 324 SITE 4 AC2 17 ILE B 327 ILE B 328 HIS B 413 HOH B2010 SITE 5 AC2 17 HOH B2038 SITE 1 AC3 11 ARG A 258 PRO A 431 LEU A 432 GLU A 435 SITE 2 AC3 11 HOH A2066 LEU B 275 GLN B 278 VAL B 279 SITE 3 AC3 11 LEU B 282 LYS B 283 VAL B 286 SITE 1 AC4 8 THR A 261 LEU A 275 LEU A 282 LYS A 283 SITE 2 AC4 8 ILE A 436 ARG B 258 PRO B 431 GLU B 435 SITE 1 AC5 7 PHE A 274 ASN A 276 MET A 365 PRO B 236 SITE 2 AC5 7 TYR B 247 CYS B 251 SER B 428 CRYST1 37.749 112.009 152.573 90.00 95.71 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026491 0.000000 0.002649 0.00000 SCALE2 0.000000 0.008928 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006587 0.00000